findmyKOL
Clinical trialNCT04467801UnknownPhase 2Interventional

Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

SponsorJun Zhang, MD, PhDEnrollment60NSCLC Stage IIIBNSCLC Stage IV
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the University of Kansas Cancer Center (kucc)

    Fairway, Kansas, United States

    Recruiting
  • the University of Kansas Cancer Center, Westwood Campus

    Kansas City, Kansas, United States

    Recruiting
  • the University of Kansas Cancer Center, Overland Park Clinic

    Overland Park, Kansas, United States

    Active, not recruiting
  • the University of Kansas Cancer Center, North Clinic

    Kansas City, Missouri, United States

    Active, not recruiting
  • the University of Kansas Cancer Center, Lee'S Summit Clinic

    Lee's Summit, Missouri, United States

    Active, not recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Sept 2021
Primary completion
31 Aug 2024
Completion
31 Aug 2025
Last update posted
7 Nov 2023
Registered enrollment
60
Registry id
NCT04467801

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.